Month: May 2020

GAITHERSBURG, Md., May 13, 2020 (GLOBE NEWSWIRE) — Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today reported financial results and provided program highlights for the first quarter ended March 31, 2020.“With the PDUFA date for our lead product candidate, inebilizumab, approaching in about one month, we are nearing another major company milestone—our first potential U.S. regulatory approval,” said Bing Yao, Ph.D., Chief Executive Officer at Viela Bio. “In anticipation, our field teams have been hard at work continuing to prepare for the potential product launch. Based on positive efficacy and safety data in the pivotal N-MOmentum trial—which studied a broad, real-world spectrum of adults with neuromyelitis optica spectrum disorder, or NMOSD—we...

NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) virtually due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of meeting participants.The Annual Meeting will be held in a virtual-only format on May 27, 2020, at 10:00 a.m., Eastern Time. Stockholders will not be able to attend the Annual Meeting in person, however, stockholders of record and registered beneficial owners as of the close of business on April 6, 2020, will be able to vote and ask questions during the meeting through the online platform.Attending...

ROLLING MEADOWS, Ill., May 13, 2020 (GLOBE NEWSWIRE) — Cambium Networks Corporation (“Cambium Networks”) (NASDAQ: CMBM), a leading provider of wireless networking infrastructure solutions, announced today that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and recommendations from government authorities, the location of the Company’s 2020 Annual Meeting of Shareholders (including any adjournments or postponements, the “Annual Meeting”) has been changed to a virtual-only format.As previously announced, the Annual Meeting will be held at 10:00 a.m. Pacific Time on Wednesday, June 3, 2020. Shareholders will not be able to attend the Annual Meeting in person. In order to attend the Annual Meeting virtually, shareholders must register in advance at https://www.proxydocs.com/CMBM prior...

ATLANTA, May 13, 2020 (GLOBE NEWSWIRE) — Williams Industrial Services Group Inc. (OTCQX: WLMS) (“Williams” or the “Company”), a construction and maintenance services company, today reported its financial results for the fiscal first quarter ended March 31, 2020.Recent HighlightsWilliams posted revenue of $66.1 million for the first quarter of 2020, up 30.6% over the prior-year periodThe Company reported a net loss of $1.0 million, or $(0.05) per share, in the first quarter of 2020 compared with net income of $0.3 million, or $0.02 per share, in the first quarter of 2019, reflecting revenue mix, project delays due to COVID-19 and other factors, and the timing of certain selling, general, and administrative (“SG&A”) expensesAdjusted EBITDA1 was $1.6 million for the first quarter of 2020 versus $2.4 million for the first quarter...

EAGLE, Idaho, May 13, 2020 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the first quarter of fiscal year 2020, reporting GAAP diluted earnings per share of $0.10 for the quarter and adjusted diluted earnings per share of $0.16 for the quarter(1).First Quarter HighlightsTotal revenue was $91.8 million, an increase of $13.9 or 17.9% over the prior year quarter and Adjusted EBITDA for the first quarter was $7.5 million, an increase of $1.2 million  or 18.3% over the prior year quarter; GAAP earnings per share of $0.10 represents an increase of 100.0% over the prior year quarter, adjusted earnings per share of $0.16 represents an increase of 23.1% over the spin-adjusted prior...

Reference is made to the company’s stock exchange release on 13 May 2020 where the notice to the company’s annual general meeting on 3 June 2020 is attached. Please find enclosed an amended Proxy form with voting instructions where the name of Cecilie Fredriksen has been added under item 11 “Election of new board members and a new Deputy Chairperson”. This is in accordance with the proposal in item 11 of the notice and the recommendation of the nomination committee that she is re-elected as a board member. An updated Proxy form with voting instructions will be submitted to the company’s shareholders.This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentAmended Proxy form with voting instructions AGM 2020 13 May 2020

Det vises til selskapets børsmelding 13. mai 2020 hvor innkallingen til selskapets ordinære generalforsamling 3. juni 2020 er vedlagt. Vedlagt følger et oppdatert Fullmaktsskjema med stemmeinstruks hvor navnet til Cecilie Fredriksen er lagt inn under punkt 11 “Valg av nye styremedlemmer og ny nestleder”. Det fremgår av punkt 11 i innkallingen og av valgkomiteens innstilling at hun foreslås gjenvalgt som styremedlem. Oppdatert Fullmaktsskjema med stemmeinstruks vil bli sendt selskapets aksjonærer.Denne informasjonen er informasjonspliktig i henhold til verdipapirhandelloven § 5-12.AttachmentEndret Fullmaktsskjema med stemmeinstruks AGM 2020 13 May 2020

–   First Quarter 2020 Revenue Grew 82% Year-Over-Year to $54.2 Million   ––   Pro Forma First Quarter 2020 Revenue, Including Revenue from Partnerships in Unowned Period, of $56.6 Million   ––   First Quarter 2020 Organic Plus “MGA of the Future” Revenue Growth of 12%   –TAMPA, Fla., May 13, 2020 (GLOBE NEWSWIRE) — BRP Group, Inc. (“BRP Group” or the “Company”) (NASDAQ: BRP), a rapidly growing independent insurance distribution firm delivering tailored insurance solutions, today announced its results for the quarter ended March 31, 2020.FIRST QUARTER 2020 AND SUBSEQUENT EVENT HIGHLIGHTS“Our strong start to 2020 highlights the resiliency of our business and continues to validate the strength of our hybrid growth model,” said Trevor Baldwin, Chief Executive Officer of BRP Group.  “Our ‘MGA of the...

– Silver Slipper Anticipates Reopening by May 22, 2020

BOSTON, May 13, 2020 (GLOBE NEWSWIRE) — Phoenix Tissue Repair, Inc. (PTR), an affiliate company of BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced updates to its ongoing Phase 1/2 study of PTR-01 (BridgeBio designation BBP-589), an intravenously-administered recombinant collagen 7 protein replacement therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB). Cohorts 1 – 3 have completed treatment at escalating dose levels, and an additional fourth cohort to evaluate higher dosing of PTR-01 has begun enrolling patients.Based on an interim review of data from the first three cohorts of trial participants, PTR-01 has been well tolerated in all nine patients, and there have been no treatment-related serious adverse events at any dose. In addition, as assessed by our investigators, there has been a dose-dependent...